Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: High-dose Chemotherapy With Rituximab for Adults With Aggressive Large B-cell Lymphoma [Phase 2]
This update reports results from a Phase 2 trial of high-dose chemotherapy with rituximab in adults with aggressive diffuse large B-cell lym…
-
CLINICAL_TRIALS trial_result · 2009-08-13Clinical Trial Update: A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 study evaluating lenalidomide in combination with dexamethasone for relapsed or refractory diffuse large B-cell lymphoma was termina…
-
CLINICAL_TRIALS trial_result · 2009-08-11Clinical Trial Update: Clinical Trial to Evaluate the Safety and Efficacy of Treosulfan Based Conditioning Prior to Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) [Phase 2]
Phase 2 clinical trial evaluating treosulfan-based conditioning prior to allogeneic hematopoietic stem cell transplantation, focusing on saf…
-
CLINICAL_TRIALS trial_result · 2009-05-07Clinical Trial Update: Phase II Trial of Thalidomide in Refractory/Relapsed Diffuse Large B-Cell Lymphoma and Hodgkin's Disease [Phase 2]
A Phase II trial of thalidomide in refractory/relapsed diffuse large B-cell lymphoma and Hodgkin lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2009-04-07Clinical Trial Update: Oblimersen, Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma [Phase 1]
Phase 1 study evaluating a combination of oblimersen with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone in patients …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-02-25Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Subsequent Treatment With the Zevalin (Ibritumomab Tiuxetan) in Elderly (More Than 60 Years) Patients With Diffuse Large B Cell Lymphoma After 4 Cycles of CHOP21-Rituximab (CHOP21-R) Therapy [Phase 2]
A Phase 2 study assessing the efficacy and safety of Zevalin (ibritumomab tiuxetan) as subsequent therapy in elderly patients with Diffuse L…
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Stem Cell Transplantation With or Without Rituximab in Treating Patients With Relapsed or Progressive B-Cell Diffuse Large Cell Lymphoma [Phase 3]
This Phase 3 clinical trial evaluated stem cell transplantation with or without Rituximab in patients with relapsed or progressive Diffuse L…
-
CLINICAL_TRIALS trial_result · 2009-02-03Clinical Trial Update: Adjuvant Low Dose Total Body Irradiation in Elderly Patients With Diffuse Large B-Cell Lymphoma [Phase 2]
This report notes the completion of a Phase 2 trial evaluating adjuvant low-dose total body irradiation in elderly patients with diffuse lar…
-
CLINICAL_TRIALS trial_result · 2008-10-20Clinical Trial Update: Phase II Study With Rituximab and Cyclophosphamide, Doxorubicin, Vincristine, Prednisone (CHOP) in Patients With Gastric Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase II trial evaluating rituximab with CHOP chemotherapy for primary gastric diffuse large B-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2008-05-07Clinical Trial Update: Large Cell Lymphoma Pilot Study III [NA]
This is a completed update on St. Jude's Large Cell Lymphoma Pilot Study III, a clinical trial investigating treatment for large cell/non-Ho…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Pilot Protocol for the Treatment of Patients With Small Non-Cleaved and Diffuse Large Cell Lymphomas [Phase 2]
Clinical trial update reporting completion of a Phase 2 pilot protocol for the treatment of Burkitt lymphoma and diffuse large B-cell lympho…
-
CLINICAL_TRIALS trial_result · 2007-11-14Clinical Trial Update: R-MegaCHOP-ESHAP-BEAM in Patients With High-Risk Aggressive B-Cell Lymphomas [Phase 2]
This is a completed Phase 2 clinical trial evaluating the R-MegaCHOP-ESHAP-BEAM regimen in high-risk aggressive B-cell lymphomas, including …
-
CLINICAL_TRIALS trial_result · 2007-11-09Clinical Trial Update: Rituximab in Addition to Chemotherapy With Autologous Stem Cell Transplantation as Treatment Diffuse Large B-Cell Lymphoma [Phase 2]
A Phase 2 trial evaluating rituximab in addition to chemotherapy with autologous stem cell transplantation for poor-prognosis Diffuse Large …
-
CLINICAL_TRIALS trial_result · 2007-07-13Clinical Trial Update: ACVBP Followed by ASCT in Patients With BCL-2 Positive Diffuse Large B-Cell Lymphoma [Phase 2, Phase 3]
This trial update reports a completed Phase 2/3 study evaluating the ACVBP chemotherapy regimen followed by autologous stem cell transplant …
-
CLINICAL_TRIALS trial_result · 2007-01-31Clinical Trial Update: Treatment of Good Prognosis, BCL-6 Negative Diffuse Large Cell Lymphoma With CHOP-R in Patients < 61 Years Old.
A clinical trial evaluates CHOP-R therapy for good-prognosis, BCL-6 negative diffuse large B-cell lymphoma in patients under 61 years old.
-
CLINICAL_TRIALS trial_result · 2006-10-06Clinical Trial Update: Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL [Phase 2]
Phase 2 clinical trial evaluating treatment for relapsed or primary refractory aggressive B-cell non-Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2006-09-26Clinical Trial Update: A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status. [Phase 2]
This document provides an update on a Phase 2 dose-dense regimen using Doxil (liposomal doxorubicin) with CDOP/rituximab for patients with d…